ENS@T operates in five core Working Groups and an early career committee

ACC Working Group

Barbara Altieri, MD, PhD

Endocrinology, Department of Medicine and Surgery,

University Hospital, University of Parma, 

Parma, Italy

and

Division of Endocrinology, Department of Internal Medicine I,

University Hospital, University of Würzburg,

Würzburg, Germany

Barbara Altieri is Associate Professor in Endocrinology at the Department of Medicine and Surgery at the University of Parma, Italy. She maintains a longstanding collaboration with the University Hospital of Würzburg, Germany, where she previously worked as Clinician Scientist.

She obtained her medical degree from the Catholic University of the Sacred Heart in Rome, where she also completed her specialization in Endocrinology and Metabolic Diseases. She later earned a PhD with Doctor Europaeus qualification, reflecting her international academic engagement.

Barbara’s scientific focus is on the translational research of adrenocortical tumorsand hypercortisolism, with a particular emphasis on unraveling the pathogenesis of ACC and exploring innovative therapeutic strategies to improve patient outcomes.

Period in office: 2025-2028

Scientific Board:
Cristina Ronchi, Birmingham, UK
Rossella Libe, Paris, France
Letizia Canu, Florence, Italy
Matthias Kroiss, Munich, Germany
Enzo Lalli, Nice, France

period in office: 2024-2027



Pheo/PPGL Working Group

Dr Judith FAVIER

Research Director, Head of the Genetics and Metabolism of Rare Cancers Laboratory, INSERM U970 – Paris-Cardiovascular Research Centre of the Georges Pompidou Hospital (HEGP), University Paris, Paris, France

Judith Favier was trained as a molecular and cellular biologist as a PhD at the Collège de France (Paris) and a post-doctoral fellow at the Montreal Heart Institute (Canada), during which she studied the role of HIF2a in angiogenesis. Since, her main research interest has been the study of the genetics and the biology of pheochromocytomas and paragangliomas with a particular focus on SDHB-mutated tumors. She holds a Research Director position in the French National Institute of Health and Medical Research (INSERM) and leads the team “Genetics and Metabolism of Rare Cancers” at the PARCC-HEGP. She is the Co-Chairman of the «Animals models» working group of the Pheochromocytoma Research Support Organization (PRESSOR) and was the previous co-chair of PRESSOR (2015-2018). She is an Associate Editor at the Endocrine-related Cancer journal.

Period in office as Head of PPGL WG and treasurer: 2021-2024 and 2025-2027

Scientific Advisory Board:
Henri Timmers, Nijmegen, The Netherlands
Mercedes Robledo, Madrid, Spain
Akiyo Tanabe, Tokyo, Japan
Elena Rapizzi, Florence, Italy
Rodrigo Toledo, Barcelona, Spain

period in office: 2021-2026


APA Working Group

Peter Igaz, MD, MSc, PhD, DSc

Head of the Department of Endocrinology

Semmelweis University

Dept. of Endocrinology, Dept. of Internal Medicine and Oncology, ENETS center of excellence, ENSAT research center of excellence

Budapest, Hungary

Peter Igaz is full professor of internal medicine and endocrinology. He is currently the head of the Department of Endocrinology at the Department of Internal Medicine and Oncology, Semmelweis University. Between July 2016 and May 2020, he served as the director of the 2nd Department of Internal Medicine, Semmelweis University that under his leadership was awarded the Center of Excellence Title of the European Neuroendocrine Tumor Society in 2019. He is Co-Head of this ENETS Center of Excellence. In 2020, his research group was awarded the title of Research Center of Excellence by ENSAT. He has boarding exams in internal medicine, endocrinology, clinical genetics and clinical oncology. Beside his medical degree (MD), Dr. Igaz has degrees in biology (MSc, molecular biology) and laws (JD). He was awarded the PhD in 1999 and the Doctor of Sciences (DSc) by the Hungarian Academy of Sciences in 2013. His research focus includes the study of microRNAs, bioinformatics, adrenal tumors, hereditary endocrine neoplasia syndromes. Dr. Igaz has authored over 170 scientific papers and edited three books (Igaz P (Ed.): Circulating microRNAs in disease diagnostics and their potential biological relevance, Springer, 2015, Igaz P-Patócs A (Eds): Genetics of Endocrine Diseases and Syndromes, Springer, 2019, and Igaz P (Ed.): Practical Clinical Endocrinology, Springer, 2021). Moreover, he has written the popular science book of endocrinology: Hormonal Diseases, a Guide for the Layperson (Springer, 2024). He is an associate editor for the journal Endocrine Related Cancer.

Period in office as Head of APA WG: 2025-2027

Scientific Advisory Board:

Marcus Quinkler, Berlin, Germany
Sheerazed Boulkroun, Paris, France
Mitsuhide Naruse, Kyoto, Japan
Aleksander Prejbisz, Warsaw, Poland

Marta Araujo-Castro, Madrid, Spain

period in office: 2022-2026


NAPACA Working Group

Guido di Dalmazi, MD

Unit of Endocrinology and Diabetes Prevention and Care

Department of Medical and Surgical Sciences 

Alma Mater Studiorum University of Bologna

IRCCS S. Orsola Policlinic

Bologna (Italy)

Guido Di Dalmazi is an Associate Professor in Endocrinology at the Division of Endocrinology and Prevention and Care of Diabetes in the Department of Medical and Surgical Sciences at the University of Bologna. He is the Director of the School of Specialization in Endocrinology of the University of Bologna. His research field focuses on adrenocortical tumors, with specific focus on hypercortisolism and adrenocortical cancer. Prof. Di Dalmazi is a member of several National and International Societies. He is coordinator of the Adrenal group of the Italian Society of Endocrinology and serves as Associate Editor for the Journal of Endocrinological investigation.

Period in office as Head of NAPACA WG: 2025-2027

Scientific Advisory Board:

Cristina L Ronchi, Birmingham, UK
Martin Fassnacht, Würzburg, Germany
Darko Kastelan, Zagreb, Croatia
Iacopo Chiodini, Milan, Italy
Anna Angelousi, Athens, Greece

period in office: 2024-2027

KIDS Working Group

Christina Pamporaki, MD, PhD, PD habil

Department of Internal Medicine III,

University Hospital Carl Gustav Carus,

Dresden, Germany

Dr. Christina Pamporaki is a consultant endocrinologist and  heads the Clinical Research Adrenal Unit at the University Hospital Carl Gustav Carus in Germany. She received her medical degree and completed her PhD Thesis at the University of Ioannina, School of Medicine, in Greece. She has acquired the specialty of “Internal Medicine, Endocrinology and Diabetes” and her Habilitation in “Internal Medicine and Endocrinology” at the Department of Internal Medicine III in the University Hospital Carl Gustav Carus, in Dresden, Germany. Dr. Pamporaki´s research interests focus on adrenal disorders, endocrine hypertension as well as on the application of laboratory analytics in clinical trials. 

period in office: 2025-2027

Scientific Advisory Board:

Ruth Casey, Cambridge, UK